EverSource Wealth Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

EverSource Wealth Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.07K	Buy	152 +128	+533%	+$2.58K	﹤0.01%	3521
2026 Q1	$470	Sell	24 -66	-73%	-$1.61K	﹤0.01%	4078
2025 Q4	$2.41K	Sell	90 -10	-10%	-$258	﹤0.01%	3429
2025 Q3	$2.67K	Sell	100 -159	-61%	-$4.11K	﹤0.01%	3417
2025 Q2	$5.95K	Buy	259 +255	+6,375%	+$6.33K	﹤0.01%	3082
2025 Q1	$116	Buy	4 +3	+300%	+$96	﹤0.01%	3806
2024 Q4	$37	Buy	+1	New	+$46	﹤0.01%	3661
2024 Q1	–	Sell	-60	Closed	-$3.71K	–	2900
2023 Q4	$3.71K	Buy	+60	New	+$3.15K	﹤0.01%	1977

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EverSource Wealth Advisors's AMPH Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Amphastar Pharmaceuticals (AMPH) stake by 533% in Q2 2026, buying an estimated $2.58K and bringing the position to 152 shares worth $3.07K. The position accounts for ﹤0.01% of the portfolio, ranked #3521.

EverSource Wealth Advisors first reported a position in AMPH in Q4 2023 and has held it in 8 quarters since. The position peaked at $5.95K in Q2 2025. 211 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

EverSource Wealth Advisors held 152 shares of Amphastar Pharmaceuticals worth $3.07K as of Q2 2026.
EverSource Wealth Advisors bought 128 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $2.58K.
Amphastar Pharmaceuticals made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3521 holding.
EverSource Wealth Advisors first reported a position in Amphastar Pharmaceuticals in Q4 2023 and has held it in 8 quarters since.
EverSource Wealth Advisors's Amphastar Pharmaceuticals position peaked at $5.95K in Q2 2025.
211 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.